Skip to Content

Clinical Proteomics Technologies for Cancer

  1. Contact Us
  2. Intranet
  3. Sign Up for Email Updates
Ovarian Cancer insight illustration

Proteogenomics Identifies New Biology in Ovarian Cancer and Insights to Diagnosis and Treatment

For more information click here.
For Cell article click here.

Clinical Proteomic Tumor Analysis ConsortiumCPTAC flyer

The National Cancer Institute (NCI), part of the National Institutes of Health, announced the launch of a Clinical Proteomic Tumor Analysis Consortium (CPTAC) in August 2011. CPTAC is a comprehensive and coordinated effort to accelerate the understanding of the molecular basis of cancer through the application of robust, quantitative, proteomic technologies and workflows. The overarching goal of CPTAC is to improve our ability to diagnose, treat and prevent cancer. Read more.  

Selected Publications

  • Zhang, H, Liu T, Zhang Z, Payne S. et al (2016) Integrated proteogenomic characterization of human high grade serous ovarian cancer. Cell . http://www.cell.com/cell/home.
  • Mertins P, et al (2016) Proteogenomic Analysis of Human Breast Cancer Connects Genetic Alterations to Phosphorylation Networks Nature . http://www.nature.com/nature.
  • Xu Z, Wu C, Xie F, Slysz GW, Tolić N, Monroe ME, Petyuk VA, Payne SH, Fujimoto GM, Moore RJ, Fillmore TL, Schepmoes AA, Levine DA, Townsend RR, Davies SR, Li S, Ellis M, Boja E, Rivers R, Rodriguez H, Rodland KD, Liu T, Smith RD. (2014) Comprehensive Quantitative Analysis of Ovarian and Breast Cancer Tumor Peptidomes. J Proteome Res. Epub ahead of print . View PubMed abstract..

View All »

U.S. Department of Health and Human Services  |  National Institutes of Health  |  National Cancer Institute  |  USA.gov

NIH…Turning Discovery Into Health®